Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity

[1]  C. McArthur,et al.  HIV Capsid Inhibitors Beyond PF74 , 2019, Diseases.

[2]  A. Merlino,et al.  Cathepsin L Inhibitors with Activity against the Liver Fluke Identified From a Focus Library of Quinoxaline 1,4-di-N-Oxide Derivatives , 2019, Molecules.

[3]  R. Pérez-Montfort,et al.  Medical and Veterinary Importance of the Moonlighting Functions of Triosephosphate Isomerase. , 2019, Current protein & peptide science.

[4]  R. Pérez-Montfort,et al.  Novel and Selective Rhipicephalus microplus Triosephosphate Isomerase Inhibitors with Acaricidal Activity , 2018, Veterinary sciences.

[5]  C. Guillon,et al.  Looking for Novel Capsid Protein Multimerization Inhibitors of Feline Immunodeficiency Virus , 2018, Pharmaceuticals.

[6]  Brian M. Suzuki,et al.  Effect of Phenotypic Screening of Extracts and Fractions of Erythrophleum ivorense Leaf and Stem Bark on Immature and Adult Stages of Schistosoma mansoni , 2018, Journal of parasitology research.

[7]  E. Carrilho,et al.  Comparative Proteomics Reveals Characteristic Proteins on Praziquantel-resistance in Schistosoma mansoni , 2018, bioRxiv.

[8]  Guzmán Ignacio Álvarez Touron.  Bioguided Design of Trypanosomicidal Compounds: A Successful Strategy in Drug Discovery. , 2018 .

[9]  Guzmán Ignacio Álvarez Touron.  Bioguided Design of Trypanosomicidal Compounds: A Successful Strategy in Drug Discovery. , 2018, Methods in molecular biology.

[10]  I. Ali,et al.  Imidazoles as potential anticancer agents. , 2017, MedChemComm.

[11]  I. Anegon,et al.  Heme-Oxygenase-1 Expression Contributes to the Immunoregulation Induced by Fasciola hepatica and Promotes Infection , 2017, Front. Immunol..

[12]  R. Abagyan,et al.  Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target , 2017, PLoS neglected tropical diseases.

[13]  Nandini A. Sahasrabuddhe,et al.  Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma , 2017, Scientific Reports.

[14]  L. Moretta,et al.  KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing , 2017, Front. Immunol..

[15]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[16]  J. Tort,et al.  Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach , 2016, PLoS neglected tropical diseases.

[17]  R. Pérez-Montfort,et al.  Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity , 2016, ChemMedChem.

[18]  T. Beddoe,et al.  Current Threat of Triclabendazole Resistance in Fasciola hepatica. , 2016, Trends in parasitology.

[19]  Brian M. Suzuki,et al.  Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni , 2016, PLoS neglected tropical diseases.

[20]  Hugo Cerecetto,et al.  Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity. , 2015, Journal of molecular graphics & modelling.

[21]  R. Wetzel,et al.  Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiency. , 2015, Biochimica et biophysica acta.

[22]  Marcelo Fernández,et al.  Identification of a New Amide-Containing Thiazole as a Drug Candidate for Treatment of Chagas' Disease , 2014, Antimicrobial Agents and Chemotherapy.

[23]  J. P. Loria,et al.  Enzyme Architecture: The Effect of Replacement and Deletion Mutations of Loop 6 on Catalysis by Triosephosphate Isomerase , 2014, Biochemistry.

[24]  D. Timson,et al.  Biochemical characterisation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from the liver fluke, Fasciola hepatica. , 2014, Biochimica et biophysica acta.

[25]  Leticia Pérez-Díaz,et al.  New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition , 2014, Journal of enzyme inhibition and medicinal chemistry.

[26]  D. Timson,et al.  Biochemical characterisation of triose phosphate isomerase from the liver fluke Fasciola hepatica. , 2013, Biochimie.

[27]  R. Pérez-Montfort,et al.  1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition , 2013, Journal of enzyme inhibition and medicinal chemistry.

[28]  S. Mukherjee,et al.  Crystal structures of triosephosphate isomerase from methicillin resistant Staphylococcus aureus MRSA252 provide structural insights into novel modes of ligand binding and unique conformations of catalytic loop. , 2012, Biochimie.

[29]  V. Gladyshev,et al.  Identification of Thioredoxin Glutathione Reductase Inhibitors That Kill Cestode and Trematode Parasites , 2012, PloS one.

[30]  Nathaniel Echols,et al.  The Phenix software for automated determination of macromolecular structures. , 2011, Methods.

[31]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[32]  R. Pérez-Montfort,et al.  Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity. , 2010, European journal of medicinal chemistry.

[33]  Thomas A. Smith,et al.  In Vivo and In Vitro Sensitivity of Fasciola hepatica to Triclabendazole Combined with Artesunate, Artemether, or OZ78 , 2010, Antimicrobial Agents and Chemotherapy.

[34]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[35]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[36]  Catalina Carrasco-Pozo,et al.  New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies. , 2009, Bioorganic & medicinal chemistry.

[37]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[38]  R. Kaminsky,et al.  In vitro selection of Haemonchus contortus for benzimidazole resistance reveals a mutation at amino acid 198 of beta-tubulin. , 2009, Molecular and biochemical parasitology.

[39]  J. Dalton,et al.  Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[40]  Conor R. Caffrey,et al.  Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening , 2009, PLoS neglected tropical diseases.

[41]  Giovanna Zinzalla,et al.  Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. , 2009, Future medicinal chemistry.

[42]  Huifeng Wu,et al.  Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy. , 2009, Toxicology and applied pharmacology.

[43]  C. Pérez,et al.  Non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors: study of structural requirements for thiadiazolidinone derivatives. , 2008, Bioorganic & medicinal chemistry.

[44]  A. Rodríguez‐Romero,et al.  Perturbation of the Dimer Interface of Triosephosphate Isomerase and its Effect on Trypanosoma cruzi , 2007, PLoS neglected tropical diseases.

[45]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[46]  Adam R Renslo,et al.  Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.

[47]  V. Arán,et al.  Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies. , 2006, Bioorganic & medicinal chemistry.

[48]  N. Chabot,et al.  Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei. , 2006, Journal of medicinal chemistry.

[49]  S. Kain,et al.  Growth of wildtype and mutant E. coli strains in minimal media for optimal production of nucleic acids for preparing labeled nucleotides , 2010, Applied Microbiology and Biotechnology.

[50]  A. Rodríguez‐Romero,et al.  Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface. , 2004, Journal of molecular biology.

[51]  Ian W. Davis,et al.  Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.

[52]  A. Rodríguez‐Romero,et al.  Structure and inactivation of triosephosphate isomerase from Entamoeba histolytica. , 2002, Journal of molecular biology.

[53]  S. Ávila-Ríos,et al.  Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi. , 2002, Biochemical and biophysical research communications.

[54]  H. Balaram,et al.  Inhibition of Plasmodium falciparum Triose-phosphate Isomerase by Chemical Modification of an Interface Cysteine , 2002, The Journal of Biological Chemistry.

[55]  I. Fairweather,et al.  Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole , 2002, Parasitology.

[56]  D. Rakus,et al.  Kinetic properties of pig (Sus scrofa domestica) and bovine (Bos taurus) D-fructose-1,6-bisphosphate 1-phosphohydrolase (F1,6BPase): liver-like isozymes in mammalian lung tissue. , 2000, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[57]  OECD GUIDELINE FOR THE TESTING OF CHEMICALS Acute Oral Toxicity : Up-and-Down Procedure , 1998 .

[58]  J. Martial,et al.  Crystal structure of recombinant human triosephosphate isomerase at 2.8 Å resolution. Triosephosphate isomerase‐related human genetic disorders and comparison with the trypanosomal enzyme , 1994, Protein science : a publication of the Protein Society.

[59]  P. Köhler,et al.  Fasciola hepatica: action in vitro of triclabendazole on immature and adult stages. , 1987, Experimental parasitology.

[60]  R. Fetterer.  The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica. , 1986, Journal of veterinary pharmacology and therapeutics.

[61]  P. Basch.  Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing. , 1981, The Journal of parasitology.

[62]  A. Tielens,et al.  Fasciola hepatica: simple, large-scale, in vitro excystment of metacercariae and subsequent isolation of juvenile liver flukes. , 1981, Experimental parasitology.

[63]  C. Haringa,et al.  The Challenge of the Future. , 1960, Canadian journal of comparative medicine and veterinary science.

[64]  Ballard,et al.  Overview of the CCP 4 suite and current developments , 2022 .